HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Role of dysregulation of Bim in resistance of melanoma cells to endoplasmic reticulum stress-induced apoptosis].

AbstractOBJECTIVE:
To establish a model of ER stress-induced apoptosis with tunicamycin and to examine whether Bim is dysregulated and its potential role in resistance of melanoma cells to apoptosis under endoplasmic reticulum (ER) stress.
METHODS:
A model of ER stress-induced apoptosis was established with tunicamycin. Apoptotic cells were quantitated using the annexin V/propidium iodide method by flow cytometry. Hoechst staining was also used to confirm the apoptotic cell death. Western blotting was used to measure the activation of caspase-3 and -9, and the expression of Bim, GRP78, CHOP, and Foxo1 at the protein level. The expression of Bim, CHOP and Foxo1 at the mRNA level was quantitated by qPCR. The siRNA technique was used to inhibit the expression of Bim.
RESULTS:
Treatment of the melanoma cells with tunicamycin did not induce significant apoptosis and activation of caspase cascade, whereas it caused marked activation of caspase-3 and -9, and apoptosis in HEK293 cells which were used as a control. With exposure to tunicamycin (3 µmol/L) for 12, 24, 36 hours the Bim protein levels were not increased in Mel-RM and MM200 cells. Its mRNA levels were 0.37 ± 0.05, 0.13 ± 0.02 and 0.02 ± 0.01 in Mel-RM cells, while 0.41 ± 0.06, 0.16 ± 0.04 and 0.21 ± 0.03 in MM200 cells, respectively. The expression of Bim mRNA was significantly reduced compared with that in the control groups of the two cell lines (P < 0.01). siRNA knockdown of Bim protected HEK293 cells against activation of caspase-3. The cell apoptosis of Bim siRNA group was (5.69 ± 0.38)%, significantly lower than that of the siRNA control group (40.32 ± 1.64)% and blank control group (35.46 ± 2.01)% (P < 0.01). In the melanoma cells after exposure to tunicamycin (3 µmol/L) for 6, 12, 24, and 36 hours the transcription factor CHOP at mRNA level were significantly increased and the expressions at protein level were also up-regulated. The expressions of another transcription factor Foxo1 at mRNA level significantly decreased and the expressions at protein level were down-regulated, too.
CONCLUSIONS:
The lack of Bim up-regulation contributes to the resistance of melanoma cells to ER stress-induced apoptosis and may be a mechanism by which melanoma cells adapt to ER stress conditions. Transcription factors CHOP and Foxo1 may be responsible for the dysregulation of Bim in melanoma cells upon ER stress.
AuthorsLi-li Hou, Lei Jin, Chuan-chun Han, Bing Cheng, Li Wang, Xu-dong Zhang, Lin-jie Zhang
JournalZhonghua zhong liu za zhi [Chinese journal of oncology] (Zhonghua Zhong Liu Za Zhi) Vol. 33 Issue 7 Pg. 494-8 (Jul 2011) ISSN: 0253-3766 [Print] China
PMID22093624 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apoptosis Regulatory Proteins
  • BCL2L11 protein, human
  • Bcl-2-Like Protein 11
  • DDIT3 protein, human
  • Endoplasmic Reticulum Chaperone BiP
  • FOXO1 protein, human
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • HSPA5 protein, human
  • Heat-Shock Proteins
  • Membrane Proteins
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • Tunicamycin
  • Transcription Factor CHOP
  • Caspase 3
  • Caspase 9
Topics
  • Apoptosis (drug effects)
  • Apoptosis Regulatory Proteins (genetics, metabolism)
  • Bcl-2-Like Protein 11
  • Caspase 3 (metabolism)
  • Caspase 9 (metabolism)
  • Cell Line, Tumor
  • Endoplasmic Reticulum Chaperone BiP
  • Endoplasmic Reticulum Stress (drug effects)
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors (genetics, metabolism)
  • HEK293 Cells
  • Heat-Shock Proteins (metabolism)
  • Humans
  • Melanoma (genetics, metabolism, pathology)
  • Membrane Proteins (genetics, metabolism)
  • Proto-Oncogene Proteins (genetics, metabolism)
  • RNA, Messenger (metabolism)
  • RNA, Small Interfering (genetics)
  • Transcription Factor CHOP (genetics, metabolism)
  • Tunicamycin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: